New drug as potential therapeutic for Asian patients with advanced Cancer
![](https://medicine.nus.edu.sg/trp/n2cr/wp-content/uploads/sites/8/2022/06/Picture4.jpg)
The drug Selinexor blocks specific protein that has been shown to be overexpressed in many types of cancer. Authors in this study evaluated the tolerability and the safety of this […]
A new protein as a target for cancer treatment
![](https://medicine.nus.edu.sg/trp/n2cr/wp-content/uploads/sites/8/2022/06/Picture3.jpg)
Any disruption in RNA processing by RNA binding proteins (RBPs) may lead to cancers. This research article published by Natures Communications and helmed by Associate Professor Polly Chen provides insights […]
Gold nanoparticles – An anticancer strategy for breast cancer patients
![](https://medicine.nus.edu.sg/trp/n2cr/wp-content/uploads/sites/8/2022/06/Picture2.jpg)
Incidence rate for breast cancer has been increasing in females globally. Immunotherapy has recently emerged as a promising anti-cancer strategy for prolonged survival in breast cancer patients. Recently, gold nanoparticles […]
New partnership with NUSMed Clinician Scientist Development Unit (CSDU)
![](https://medicine.nus.edu.sg/trp/n2cr/wp-content/uploads/sites/8/2022/06/Picture1.png)
The NUS Yong Loo Lin School of Medicine Clinician Scientist Development Unit (CSDU) provides guidance and training to develop the research careers of budding clinician-scientists in NUHS. Given the shared […]